Brand Name | Status | Last Update |
---|---|---|
alymsys | Biologic Licensing Application | 2022-04-27 |
avastin | Biologic Licensing Application | 2025-01-06 |
avzivi | Biologic Licensing Application | 2024-10-09 |
jobevne | Biologic Licensing Application | 2025-04-01 |
mvasi | Biologic Licensing Application | 2025-06-23 |
vegzelma | Biologic Licensing Application | 2025-05-08 |
zirabev | Biologic Licensing Application | 2025-08-05 |
Expiration | Code | ||
---|---|---|---|
bevacizumab, Avastin, Genentech, Inc. | |||
2027-05-29 | Orphan excl. |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Colorectal neoplasms | D015179 | — | — | 6 | 16 | 2 | 1 | 5 | 30 |
Hepatocellular carcinoma | D006528 | — | C22.0 | 3 | 10 | 1 | 2 | — | 16 |
Liver neoplasms | D008113 | EFO_1001513 | C22.0 | 2 | 10 | 1 | 2 | — | 15 |
Macular edema | D008269 | — | — | 4 | 6 | 2 | 1 | — | 9 |
Retinal vein occlusion | D012170 | EFO_1001157 | H34.81 | 1 | 1 | — | 1 | — | 2 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Non-small-cell lung carcinoma | D002289 | — | — | 10 | 41 | 2 | — | 3 | 49 |
Breast neoplasms | D001943 | EFO_0003869 | C50 | 5 | 35 | 6 | — | 3 | 48 |
Neoplasms | D009369 | — | C80 | 10 | 21 | 2 | — | 1 | 32 |
Ovarian neoplasms | D010051 | EFO_0003893 | C56 | 7 | 22 | 1 | — | 1 | 30 |
Lung neoplasms | D008175 | — | C34.90 | 5 | 22 | 3 | — | 2 | 27 |
Neoplasm metastasis | D009362 | EFO_0009708 | — | 6 | 14 | 3 | — | — | 20 |
Fallopian tube neoplasms | D005185 | — | — | 4 | 14 | 1 | — | 1 | 20 |
Renal cell carcinoma | D002292 | EFO_0000376 | — | 1 | 9 | 2 | — | 1 | 12 |
Pancreatic neoplasms | D010190 | EFO_0003860 | C25 | 5 | 6 | 1 | — | — | 11 |
Rectal neoplasms | D012004 | — | — | 2 | 5 | 1 | — | 2 | 9 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Glioblastoma | D005909 | EFO_0000515 | — | 5 | 25 | — | — | 1 | 29 |
Glioma | D005910 | EFO_0000520 | — | 6 | 17 | — | — | 2 | 22 |
Brain neoplasms | D001932 | EFO_0003833 | C71 | 4 | 16 | — | — | 1 | 18 |
Gliosarcoma | D018316 | — | — | — | 14 | — | — | — | 14 |
Prostatic neoplasms | D011471 | — | C61 | 3 | 9 | — | — | — | 10 |
Kidney neoplasms | D007680 | EFO_0003865 | C64 | 1 | 10 | — | — | — | 10 |
Stomach neoplasms | D013274 | EFO_0003897 | C16 | — | 9 | — | — | — | 9 |
Esophageal neoplasms | D004938 | — | C15 | — | 9 | — | — | — | 9 |
Sarcoma | D012509 | — | — | 3 | 5 | — | — | — | 8 |
Head and neck neoplasms | D006258 | — | — | 2 | 6 | — | — | — | 8 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Diabetic foot | D017719 | EFO_1001459 | — | 1 | — | — | — | — | 1 |
Foot ulcer | D016523 | — | — | 1 | — | — | — | — | 1 |
Healthy volunteers/patients | — | — | — | 1 | — | — | — | — | 1 |
Radiation injuries | D011832 | — | T66 | 1 | — | — | — | — | 1 |
Desmoplastic small round cell tumor | D058405 | — | — | 1 | — | — | — | — | 1 |
Neuromyelitis optica | D009471 | EFO_0004256 | G36.0 | 1 | — | — | — | — | 1 |
Diffuse intrinsic pontine glioma | D000080443 | — | — | 1 | — | — | — | — | 1 |
Salivary gland neoplasms | D012468 | EFO_0003826 | D11 | 1 | — | — | — | — | 1 |
Thyroid neoplasms | D013964 | EFO_0003841 | — | 1 | — | — | — | — | 1 |
Parotid neoplasms | D010307 | EFO_0003873 | C07 | 1 | — | — | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Central nervous system neoplasms | D016543 | — | — | — | — | — | — | 1 | 1 |
Anus neoplasms | D001005 | EFO_0003835 | C21 | — | — | — | — | 1 | 1 |
Drug common name | Bevacizumab |
INN | bevacizumab |
Description | Bevacizumab, sold under the brand name Avastin, is a medication used to treat a number of types of cancers and a specific eye disease. For cancer it is given by slow injection into a vein and used for colon cancer, lung cancer, glioblastoma, and renal-cell carcinoma. For age-related macular degeneration it is given by injection into the eye.
|
Classification | Antibody |
Drug class | monoclonal antibodies |
Image (chem structure or protein) | ![]() |
Structure (InChI/SMILES or Protein Sequence) | >7V5N:A,E|bevacizumab fab light chain
DIQMTQSPSSLSASVGDRVTITCSASQDISNYLNWYQQKPGKAPKVLIYFTSSLHSGVPSRFSGSGSGTDFTLTISSLQP
EDFATYYCQQYSTVPWTFGQGTKVEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQ
ESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC
>7V5N:B,F|bevacizumab fab heavy chain
EVQLVESGGGLVQPGGSLRLSCAASGYTFTNYGMNWVRQAPGKGLEWVGWINTYTGEPTYAADFKRRFTFSLDTSKSTAY
LQMNSLRAEDTAVYYCAKYPHYYGSSHWYFDVWGQGTLVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPV
TVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSCDKTHT |
PDB | 6BFT, 7V5N |
CAS-ID | — |
RxCUI | — |
ChEMBL ID | CHEMBL1201583 |
ChEBI ID | — |
PubChem CID | — |
DrugBank | DB00112 |
UNII ID | 2S9ZZM9Q9V (ChemIDplus, GSRS) |